In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Aptus Endosystems brings in $15mm through its Series AA round

Executive Summary

Aptus Endosystems Inc. (treatments for aortic aneurysms) has raised $15mm through the closing of its Series AA round. Returning investors US Venture Partners and Longitude Capital led the financing. The funds will be used to finish clinical development and pursue commercialization in the US and Europe for the independent use of its endostapling system and in tandem with its endovascular AAA repair system.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies